Welcome to World ADC San Diego! The World’s Largest, Longest Standing & Definitive Antibody-Drug Conjugate Event
The ADC field continued to go from strength to strength with transformative clinical advancements for oncology patients, new companies entering the field, and game-changing ADC technologies. As the community reunited atWorld ADC San Diego, it was important to reflect and recognize the long-term cont...
Welcome to World ADC San Diego! The World’s Largest, Longest Standing & Definitive Antibody-Drug Conjugate Event
Welcome to World ADC San Diego! The World’s Largest, Longest Standing & Definitive Antibody-Drug Conjugate Event
Welcome to World ADC San Diego! The World’s Largest, Longest Standing & Definitive Antibody-Drug Conjugate Event
Friday October 11th San Diego, CA Winners announced for 6th Annual World ADC Awards. World ADC is pleased to announce the winners at the 6th Annual World ADC Awards Now in its 6th year, the World ADC Awards showcases the innovation, leadership and devoti
With linker and conjugate deals dominating the 2024 ADC industry and more companies shifting their focus towards the chemistries behind linkers and conjugations, innovations in this space are becoming akey point of differentiation to preserve a competitive edge. ...
One of my projects that focuses on circadian metabolomics in mice never worked out well previous at other companies and MS service providers due detection issues on certain extremely low-abundant metabolites. At AxisPharm, the manager David Yue and co-workers figured this out and set up a ...
Presenting a compelling case is more important than ever as the pandemic disappears from the rearview mirror and generalist investors exit healthcare. Add in high interest rates and “the only way that biotech companies can succeed in this environment is to appeal to the specialist in...
Presenting a compelling case is more important than ever as the pandemic disappears from the rearview mirror and generalist investors exit healthcare. Add in high interest rates and “the only way that biotech companies can succeed in this environment is to appeal to the specialist investors,” Ka...